Finanznachrichten4d
CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland
CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing facilities across Europe and the US.
BioSpace4d
GLP-1 Injectables Will Soon Be Joined by Orals. Is the Industry Ready to Scale?
With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for ...
Carlsbad’s Ionis strikes deal with Japanese pharma worth up to $940M
Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.
Investing4d
Truist sees growth potential in LLY, AMGN obesity treatments
In other recent news, Viking Therapeutics has announced a strategic manufacturing agreement with CordenPharma to ensure a steady supply of its obesity treatment, VK2735. This deal includes the ...
Viking Therapeutics completes enrollment in Phase 2 trial of VK2735
Viking Therapeutics (VKTX) announced the completion of subject enrollment in its Phase 2 clinical trial of the oral tablet formulation of ...
Yahoo Finance3d
Viking Therapeutics, Inc. (VKTX)
As of 1:07:14 PM EDT. Market Open. Vertex Baseline Delta ...